Similar articles

• Ristocetin in the diagnosis of von willebrand's disease: a comparison of rate and percent of aggregation with levels of the plasma factor(s) necessary for ristocetin aggregation.

  Dowling SV, Muntz RH, D'Souza S, Ekert H. Dowling SV, et al. Thromb Diath Haemorrh. 1975 Nov 15;34(2):465-74. Thromb Diath Haemorrh. 1975. PMID: 1081746
• [Use of frozen thrombocytes for the determination of von willebrand factor with the aid of ristocetin].

  Caduff T, Straub PW. Caduff T, et al. Schweiz Med Wochenschr. 1979 Mar 17;109(11):399-402. Schweiz Med Wochenschr. 1979. PMID: 34214 German.
• Platelets fixed with paraformaldehyde: a new reagent for assay of von Willebrand factor and platelet aggregating factor.

  Allain JP, Cooper HA, Wagner RH, Brinkhous KM. Allain JP, et al. J Lab Clin Med. 1975 Feb;85(2):318-28. J Lab Clin Med. 1975. PMID: 234499
• [Inborn and acquired von Willebrand disease].

  Schneppenheim R, Budde U. Schneppenheim R, et al. Hamostaseologie. 2008 Dec;28(5):312-9. Hamostaseologie. 2008. PMID: 19132162 Review. German.
• [Platelet aggregation caused by ristocetin--its implication and action mechanism].

  Izuchi Y. Izuchi Y. Nihon Rinsho. 1978 Dec 10;36(12):3848-56. Nihon Rinsho. 1978. PMID: 372624 Review. Japanese. No abstract available.